Researchers describe pegcetacoplan, a new class of medication, as the “closest thing to a cure” for the rare, severe kidney disease C3 glomerulopathy.
A rare and life-threatening kidney disease in children finally has an effective therapy, thanks in large part to pioneering ...
A federal vaccine advisory committee this week is expected to discuss whether newborns should still get the hepatitis B ...
As RFK Jr.'s new vaccine panel ponders changing the hepatitis B vaccination schedule, some doctors recall past patients, ...
The new chair of the Advisory Committee on Immunization Practices said the panel plans to vote to end universal hepatitis B ...
The three-dose hepatitis B vaccine has a long track record of safety, but rolling back recommendations could leave kids ...
Franklin Wanyama stopped his HIV medication twice due to stigma and depression, causing his viral load to explode to over ...
NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global ...
The direct-acting antiviral glecaprevir/pibrentasvir (Mavyret) was highly effective and well tolerated in adults with acute ...
A combination treatment involving tobevibart and elebsiran significantly improved disease activity in adults with chronic ...
Despite untreated HBV being linked to earlier mortality, higher all-cause and liver-related death, and a 10% to 25% lifetime risk of developing hepatocellular carcinoma (HCC), only 29% of qualifying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback